LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,321,000 | -89.7% | 8,000 | -91.5% | 0.01% | -90.0% |
| Q4 2017 | $12,859,000 | -38.5% | 93,916 | -38.9% | 0.06% | -43.9% |
| Q3 2017 | $20,915,000 | +157.9% | 153,614 | +130.0% | 0.11% | +127.7% |
| Q2 2017 | $8,109,000 | +82.7% | 66,800 | +59.3% | 0.05% | +30.6% |
| Q1 2017 | $4,439,000 | -61.9% | 41,941 | -63.4% | 0.04% | -56.6% |
| Q4 2016 | $11,646,000 | +206.0% | 114,622 | +207.3% | 0.08% | +196.4% |
| Q3 2016 | $3,806,000 | +108.5% | 37,300 | +143.8% | 0.03% | +100.0% |
| Q2 2016 | $1,825,000 | +748.8% | 15,300 | +665.0% | 0.01% | +1300.0% |
| Q1 2016 | $215,000 | -69.0% | 2,000 | -75.3% | 0.00% | -66.7% |
| Q3 2015 | $694,000 | -93.4% | 8,100 | -92.2% | 0.00% | -95.2% |
| Q2 2015 | $10,534,000 | +53.2% | 104,400 | +17.0% | 0.06% | +21.2% |
| Q1 2015 | $6,878,000 | – | 89,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |